Boston Scientific Corporation

NYSE:BSX

Market Cap

USD 159.43 B

Share Price

USD 107.76

Avg Daily Volume

7,749,481

Change (1 day)

4.46%

Change (1 year)

37.12%

Change (YTD)

20.64%

Boston Scientific Corporation EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2025: 23.31%

Boston Scientific Corporation EBITDA Margin is 23.31% for the Trailing 12 Months (TTM) ending March 31, 2025, a -5.78% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • Boston Scientific Corporation EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was 24.74%, a 13.78% change year over year.
  • Boston Scientific Corporation EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was 21.74%, a 3.12% change year over year.
  • Boston Scientific Corporation EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was 21.08%, a 32.13% change year over year.
  • Boston Scientific Corporation EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was 15.96%, a 12.85% change year over year.
Key Data
Date EBITDA Margin Net Income Margin EBT Margin Operating Income Margin